COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants

21/02/2024 - 14:00

Individual Patient EAP allows access to efzofitimod for patients who complete the Phase 3 EFZO-FIT ™ study in pulmonary sarcoidosis. Company initiating program based on blinded EFZO-FIT ™ study investigator and patient [...]

Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19

21/02/2024 - 14:00

First Medicinal chemistry of an antiviral drug made of sugars BOSTON, MASSACHUSETTS, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT ), (the “Company”), a clinical stage biotechnology company developing [...]

Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia

21/02/2024 - 14:00

Initial Orders for Sharps Securegard 1mL and 3mL Syringes are in Process, Introducing a Line of Competitively Priced, Low Waste, Smart Safety Syringes to the Colombian Healthcare System and the Latin American Market NEW [...]

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

21/02/2024 - 13:30

Positive Adjusted EBITDA* for Q4 2023 more than doubles from Q3 2023 to $5 million (Net Loss of $2.8 million) leading to a significant turnaround for the full year versus 2022 Record quarterly revenue of $23.5 million [...]

Theratechnologies présente ses résultats financiers pour le quatrième trimestre et l’exercice complet 2023 et des prévisions pour 2024

21/02/2024 - 13:30

Le BAIIA* ajusté positif de 5 millions (perte nette de 2,8 millions) de dollars pour le quatrième trimestre de 2023 a été plus de deux fois supérieur à celui du troisième trimestre de 2023, donnant lieu à un [...]

Repligen Reports Fourth Quarter and Full Year 2023 Financial Results

21/02/2024 - 13:30

Reports fourth quarter revenue of $156 million and full year revenue of $639 million Continued strength in orders with fourth quarter book-to-bill ratio of 1.03 WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Repligen [...]

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

21/02/2024 - 13:30

— CASGEVY™ approved in the U.S., European Union, Great Britain, the Kingdom of Saudi Arabia and Bahrain — — Clinical trials ongoing for next generation CAR T product candidates, CTX112™ and CTX131™ targeting CD19 and [...]

Linvoseltamab BLA for Treatment of Relapsed/Refractory Multiple Myeloma Accepted for FDA Priority Review

21/02/2024 - 13:00

TARRYTOWN, N.Y., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License [...]

Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024

21/02/2024 - 13:00

Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 21 February 2024) Immunocore Holdings [...]

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

21/02/2024 - 13:00

CAMBRIDGE, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it will host a conference call and webcast on Wednesday, February [...]

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

21/02/2024 - 13:00

Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on February 23, 2024 HOUSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH) (the “Company”), a biotechnology company [...]

Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

21/02/2024 - 13:00

EMERYVILLE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will [...]

Two of Oregon’s Favorite Craft Breweries Team Up With the Portland Timbers as Official Craft Beer Sponsors

21/02/2024 - 13:00

10 Barrel Brewing and Widmer Brothers Sign a Multi-Year Deal That Includes Creation Of First Standing Room Only Section In The Stadium PORTLAND, Ore., Feb. 21, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co . (“10 Barrel [...]

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

21/02/2024 - 13:00

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company’s debt GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. ( [...]

Verge Genomics to Present at Evercore ISI 2024 Emerging Biotech Conference

21/02/2024 - 13:00

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Verge Genomics, a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data, [...]

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

21/02/2024 - 13:00

LEXINGTON, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report fourth quarter 2023 [...]

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

21/02/2024 - 13:00

BOSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for [...]

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21/02/2024 - 13:00

ADMAlytics Combines Generative AI and Machine Learning to Optimize Production Processes ADMA Successfully Utilized ADMAlytics’ New Capabilities for the First Time to Automate and Realize Efficiency Improvements for [...]

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

21/02/2024 - 12:50

DEER PARK, Ill., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]